Notícias e Atividades da Venus Concept

Venus Concept é uma empresa listada sob o símbolo VERO (CA).

Veja o organograma con seus 24 executivos principais

Biografias mais buscadas da Venus Concept

• Rajiv De Silva, Chief Executive Officer and Director
• Keith Sullivan, Director
• Tyler Hollmig, Director

Recentes movimentos de executivos em Venus Concept

• Hemanth Varghese, President and Chief Operating Officer, deixará a Companhia em 28 de mar. de 2025  (Notícia publicada em 26 de fevereiro de 2025).
• Ross Portaro antes Executive Vice President and General Manager, Sales and Marketing, foi promovido a Executive Vice President, Commercial Strategy and Head of Venus Hair  (Notícia publicada em 26 de fevereiro de 2025).
• Kirk Gunhus, ingressou na Companhia como Chief Revenue Officer  (Notícia publicada em 26 de fevereiro de 2025).

Criar um alerta
para seguir os movimentos de executivos da Venus Concept.

Venus Concept possui 1.834 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado em 12 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Seth Harrison - Chairman and Director da Braeburn Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Venus Concept

• Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022 | Venus Concept
• Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance | Venus Concept
• Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX | Venus Concept
• Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles | Venus Concept
• Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022 | Venus Concept
• Venus Concept Submits FDA 510(k) Related to the Use of its Aime™ Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing | Venus Concept
• Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Revenue Guidance | Venus Concept
• Venus Concept Inc. to Present at the Maxim Virtual Growth Conference on March 28th | Venus Concept
• Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16th | Venus Concept
• Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022 | Venus Concept
• View more press releases Close

Redes sociais sobre Venus Concept

• Venus Concept na Wikipedia, Google News e Yahoo Finance
• Venus Concept na LinkedIn, Twitter e YouTube